HOLX · As filed with the SEC
Hologic income statement, by quarter
The statement as Hologic presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Income · USD, except per-share amounts; shares in thousands
| USD, except per-share amounts; shares in thousands | Q1 FY26 3 months ended Dec 27, 2025 | Q4 FY25† 3 months ended Sep 27, 2025 | Q3 FY25 3 months ended Jun 28, 2025 | Q2 FY25 3 months ended Mar 29, 2025 | Q1 FY25 3 months ended Dec 28, 2024 | Q4 FY24† 3 months ended Sep 28, 2024 | Q3 FY24 3 months ended Jun 29, 2024 | Q2 FY24† 3 months ended Mar 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenues: | ||||||||
| Product | — | — | — | — | — | — | — | 828,000,000 |
| Service and other | — | — | — | — | — | — | — | 189,800,000 |
| Revenues | — | — | — | — | — | — | — | 1,017,800,000 |
| Revenues | 1,047,800,000 | 1,049,600,000† | 1,023,800,000 | 1,005,300,000 | 1,021,800,000 | 988,000,000† | 1,011,400,000 | 1,017,800,000† |
| Product | 831,400,000 | 835,100,000† | 810,400,000 | 792,700,000 | 817,900,000 | 787,900,000† | 811,200,000 | 827,900,000† |
| Service | 216,400,000 | 214,500,000† | 213,400,000 | 212,600,000 | 203,900,000 | 200,100,000† | 200,200,000 | 189,900,000† |
| Costs of revenues: | ||||||||
| Cost of revenue | — | — | — | — | — | — | — | 308,600,000 |
| Amortization, Cost of Goods Sold | — | — | — | — | — | — | — | 44,900,000 |
| Impairment of intangible asset | — | — | — | — | — | — | — | 25,900,000 |
| Service and other | — | — | — | — | — | — | — | 96,100,000 |
| Product | — | — | 310,500,000 | 305,000,000 | 301,100,000 | 292,300,000† | 298,200,000 | 308,500,000† |
| Service | — | — | 95,600,000 | 91,400,000 | 94,200,000 | 92,400,000† | 95,200,000 | 96,100,000† |
| Product | 321,900,000 | — | — | — | — | — | — | — |
| Service | 98,500,000 | — | — | — | — | — | — | — |
| Amortization of acquired intangible assets | 41,000,000 | 41,200,000† | 41,100,000 | 48,200,000 | 46,000,000 | 45,600,000† | 44,400,000 | 45,000,000† |
| Impairment of intangible assets | — | — | 0 | 183,400,000 | — | — | 13,300,000 | — |
| Gross profit | 586,400,000 | 583,500,000† | 576,600,000 | 377,300,000 | 580,500,000 | 557,700,000† | 560,300,000 | 542,300,000 |
| Operating expenses: | ||||||||
| Research and development | 60,500,000 | 65,100,000† | 61,400,000 | 61,500,000 | 60,300,000 | 67,300,000† | 64,100,000 | 74,600,000 |
| Selling and marketing | 154,900,000 | 147,800,000† | 152,200,000 | 154,400,000 | 166,100,000 | 146,000,000† | 146,300,000 | 144,200,000 |
| General and administrative | 127,800,000 | 114,800,000† | 99,100,000 | 119,700,000 | 115,700,000 | 103,200,000† | 94,000,000 | 100,400,000 |
| Amortization of acquired intangible assets | 2,300,000 | 2,900,000† | 3,000,000 | 3,800,000 | 4,700,000 | 4,900,000† | 5,300,000 | 5,700,000 |
| Impairment of intangible assets | — | — | 0 | 37,500,000 | 0 | — | 400,000 | 900,000 |
| Contingent consideration fair value adjustments | — | 0† | 0 | 0 | 0 | 0† | 0 | 0 |
| Restructuring charges | 3,900,000 | 11,000,000† | 6,300,000 | 7,400,000 | 3,900,000 | 6,300,000† | 6,200,000 | 6,100,000 |
| Operating expenses | 349,400,000 | 346,600,000† | 322,000,000 | 384,300,000 | 350,700,000 | 327,700,000† | 316,300,000 | 331,900,000 |
| Income from operations | 237,000,000 | 236,900,000† | 254,600,000 | (7,000,000) | 229,800,000 | 230,000,000† | 244,000,000 | 210,400,000 |
| Interest income | 19,700,000 | 18,900,000† | 16,400,000 | 14,900,000 | 24,200,000 | 28,400,000† | 28,400,000 | 24,000,000 |
| Interest expense | — | — | (28,900,000) | (29,100,000) | (30,500,000) | (31,900,000)† | (31,900,000) | (32,300,000) |
| Interest expense | (27,600,000) | — | — | — | — | — | — | — |
| Other income | 600,000 | 0† | (7,100,000) | (7,300,000) | 24,000,000 | (4,900,000)† | 200,000 | 9,400,000 |
| Income before income taxes | 229,700,000 | 227,200,000† | 235,000,000 | (28,500,000) | 247,500,000 | 221,600,000† | 240,700,000 | 211,500,000 |
| Provision for income taxes | 50,600,000 | 40,000,000† | 40,100,000 | (11,100,000) | 46,500,000 | 43,000,000† | 46,200,000 | 41,600,000 |
| Net income | 179,100,000 | 187,200,000† | 194,900,000 | (17,400,000) | 201,000,000 | 178,600,000† | 194,500,000 | 169,900,000 |
| Net income per common share: | ||||||||
| Basic (in usd per share) | 0.80 | — | 0.87 | (0.08) | 0.87 | — | 0.83 | 0.72 |
| Diluted (in usd per share) | 0.79 | — | 0.86 | (0.08) | 0.87 | — | 0.82 | 0.72 |
| Weighted average number of shares outstanding: | ||||||||
| Basic (in shares) | 224,405 | — | 224,315 | 225,774 | 230,284 | — | 234,604 | 235,890 |
| Diluted (in shares) | 225,879 | — | 225,462 | 225,774 | 232,107 | — | 236,466 | 237,562 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.